Stereoselective syntheses of rolliniastatin 1, rollimembrin, and membranacin

Journal of the American Chemical Society

Volumn 127, Issue 29, 2005, Pages 10396-10399

  Keum, Gyochang ^a,b   Hwang, Cheol Hee ^a   Kang, Soon Bang ^b   Kim, Youseung ^b   Lee, Eun ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDES;

ALLYLATION; MOIETY; SULFOXIDES;

SYNTHESIS (CHEMICAL);

ACETOGENIN; MEMBRANACIN; NATURAL PRODUCT; ROLLIMEMBRIN; ROLLINIASTATIN 1; SULFOXIDE; UNCLASSIFIED DRUG;

ALLYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL STRUCTURE; CYCLIZATION; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; PUMMERER REACTION; ROLLINIA; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLIZATION; FURANS; LACTONES; PLANTS; SEEDS; STEREOISOMERISM; SULFOXIDES; VINYL COMPOUNDS;

EID: 22944477099     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0526867     Document Type: Article

References (39)

1. (a) Pettit, G. R.; Cragg, G. M.; Polonsky, J.; Herald, D. L.; Goswami, A.; Smith, C. R.; Moretti, C.; Schmidt, J. M.; Weisleder. D. Can. J. Chem. 1987, 65, 1433-1435.
2. (b) Saez, J.; Sahpaz, S.; Villaescusa, L.; Hocquemiller, R.; Cavé, A.; Cortes, D. J. Nat. Prod. 1993, 56, 351-356.
3. (c) González, M. C.; Tormo, J. R.; Bermejo, A.; Zafra-Polo, M. C.; Estornell, E.; Cortes, D. Bioorg. Med. Chem. Lett. 1997, 7, 1113-1118.
4. (d) Bermejo, A.; Figadère, B.; Zafra-Polo, M.-C.; Barrachina, I.; Estornell, E.; Cortes, D. Nat. Prod. Rep. 2005, 22, 269-303.
5. For introduction on Annonaceous acetogenins in general, read the following reviews. (e) Alali, F. Q.; Liu, X.-X.; McLaughlin, J. L. J. Nat. Prod. 1999, 62, 504-540.
6. (f) Rupprecht, J. K.; Hui, Y.-H.; McLaughlin, J. L. J. Nat. Prod. 1990, 53, 237-278.
7. For further studies on the bioactivity of rolliniastatin 1 and related compounds, see: Royo, I.; DePedro, N.; Estornell, E.; Cortes, D.; Peláez, F.; Tormo, J. R. Oncol. Res. 2003, 13, 521-528.
8. For more recent examples of synthetic efforts, see: (a) Nattrass, G. L.; Díez, E.; McLachlan, M. M.; Dixon, D. J.; Ley, S. V. Angew. Chem., Int. Ed. 2005, 44, 580-584.
9. (b) Zhang, Q.; Lu, H.; Richard, C.; Curran, D. P. J. Am. Chem. Soc. 2004, 126, 36-37.
10. (c) Crimmins, M. T.; She, J. J. Am. Chem. Soc. 2004, 126, 12790-12791.
11. (d) Han, H.; Sinha, M. K.; D'Souza, L. J.; Keinan, E.; Sinha, S. C. Chem.-Eur. J. 2004, 10, 2149-2158.
12. (e) Prestat, G.; Baylon, C.; Heck, M.-P.; Grasa, G. A.; Nolan, S. P.; Mioskowski, C. J. Org. Chem. 2004, 69, 5770-5773.
13. (f) Cecil, A. R. L.; Hu, Y.; Vicent, M. J.; Duncan, R.; Brown, R. C. D. J. Org. Chem. 2004, 69, 3368-3374.
14. (g) Zhu, L.; Mootoo, D. R. J. Org. Chem. 2004, 69, 3154-3157.
15. (h) Yoshimitsu, T.; Makino, T.; Nagaoka, H. J. Org. Chem. 2004, 69, 1993-1998.
16. (i) Strand, D.; Rein, T. Org. Lett. 2005, 7, 199-202.
17. (j) Makabe, H.; Hattori, Y.; Kimura, Y.; Konno, H.; Abe, M.; Miyoshi, H.; Tanaka, A.; Oritani, T. Tetrahedron 2004, 60, 10651-10657.
18. (k) Makabe, H.; Miyawaki, A.; Takahashi, R.; Hattori, Y.; Konno, H.; Abe, M.; Miyoshi, H. Tetrahedron Lett. 2004, 45, 973-977.
19. Koert, U. Tetrahedron Lett. 1994, 35, 2517-2520.
20. Head, G. D.; Whittingham, W. G.; Brown, R. C. D. Synlett 2004, 1437-1439.
21. For selected examples of stereoselective radical cyclization reactions of β-alkoxyacrylates and β-alkoxyvinyl ketones in natural product syntheis, see: (a) Kang, E. J.; Cho, E. J.; Lee, Y. E.; Ji, M. K.; Shin, D. M.; Chung, Y. K.; Lee, E. J. Am. Chem. Soc. 2004, 126, 2680-2681.
22. (b) Song, H. Y.; Joo, J. M.; Kang, J. W.; Kim, D.-S.; Jung, C.-K.; Kwak, H. S.; Park, J. H.; Lee, E.; Hong, C. Y.; Jeong, S.; Jeon, K.; Park, J. H. J. Org. Chem. 2003, 68, 8080-8087.
23. (c) Jeong, E. J.; Kang, E. J.; Sung, L. T.; Hong, S. K.; Lee, E. J. Am. Chem. Soc. 2002, 124, 14655-14662.
24. (d) Lee, E.; Choi, S. J.; Kim, H.; Han, H. O.; Kim, Y. K.; Min, S. J.; Son, S. H.; Lim, S. M.; Jang, W. S. Angew. Chem., Int. Ed. 2002, 41, 176-178.
25. (e) Lee, E.; Park, C. M.; Yun, J. S. J. Am. Chem. Soc. 1995, 117, 8017-8018.
26. For more examples on oxacycle synthesis via radical cyclization, read the following review. (f) Lee E. In Radicals in Organic Synthesis, Vol. 2: Applications; Renaud, P., Sibi, M. P., Eds.; Wiley-VCH: Weinheim, 2001; pp 303-333.
27. Keum, G.; Kang, S. B.; Kim, Y.; Lee, E. Org. Lett. 2004, 6, 1895-1897.
28. (a) Yamanaka, H.; Yokoyama, M.; Sakamoto, T.; Shiraishi, T.; Sagi, M.; Mizugaki, M. Heterocycles 1983, 20, 1541-1544.
29. (b) Harcken, C.; Bruckner, R. New J. Chem. 2001, 25, 40-54.
30. Torneiro, M.; Still, W. C. Tetrahedron 1997, 53, 8739-8750.
31. Kosugi, H.; Kitaoka, M.; Tagami, K.; Takahashi, A.; Uda, H. J. Org. Chem. 1987, 52, 1078-1082.
32. Use of ethynyl p-tolyl (R)-sulfoxide (19) in the present synthetic sequence yielded the corresponding oxolanyl product in 98% yield, but the stereoselectivity was lower (mismatched, d.r. = 16:1).
33. Lee, E.; Man, H. O. Tetrahedron Lett. 2002, 43, 7295-7296.
34. Sugihara, H.; Tanikaga, R.; Kaji, A. Synthesis 1978, 881.
35. The expected major product was the threo product via chelation model, but the erythro product 11 was the major product in this case.
36. Synthesis of ent-23 was reported in ref 7.
37. Use of the intermediates 27 and 28 was reported in ref 4.
38. For preparation of a lower homologue of 30, see: Avedissian, H.; Sinha, S. C.; Yazbak, A.; Sinha, A.; Neogi, P.; Sinha, S. C.; Keinan, E. J. Org. Chem. 2000, 65, 6035-6051.
39. For a reported use of 37 and 38 for similar purposes, see: Schaus, S. E.; Brånalt, J.; Jacobsen, E. N. J. Org. Chem. 1998, 63, 4876-4877.